Intelligent Bio Solutions Inc. (INBS)
Official siteHEALTHCARE • MEDICAL DEVICES • NASDAQ
Market Cap: $5.84M
Last updated: Nov 17, 2026 at 11:03 AM ET
Intelligent Bio Solutions Inc. (INBS) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Intelligent Bio Solutions reported EPS of -$0.86. It beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
INBS's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 18 quarters below that had an estimate, INBS beat 7 and missed 11. Revenue for the quarter ended Sep 30, 2026 was $1.39M, up 25.2% from $1.11M a year earlier.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.86 | -$1.31 | -$1.31 - -$1.31 | N/A | N/A | N/A | 1 | 0 up, 0 down | Nov 10, 2026 | $1.39M |
| Jun 30, 2026 | -$0.90 | -$1.58 | -$1.58 - -$1.58 | +43.04% | Beat | N/A | 1 | 0 up, 1 down | Aug 19, 2026 | $1.15M |
| Mar 31, 2026 | -$1.80 | $1.40 | N/A | -228.57% | Miss | N/A | N/A | N/A | May 13, 2026 | $1.06M |
| Dec 31, 2025 | -$2.82 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | Feb 12, 2026 | $896774 |
| Sep 30, 2025 | -$0.35 | -$0.27 | N/A | -29.63% | Miss | N/A | N/A | N/A | Nov 12, 2025 | $1.11M |
| Jun 30, 2025 | -$0.44 | $0.08 | N/A | -650.00% | Miss | N/A | N/A | N/A | Aug 15, 2025 | $843884 |
| Mar 31, 2025 | -$0.44 | -$0.10 | N/A | -340.00% | Miss | N/A | 1 | 0 up, 0 down | May 13, 2025 | $728867 |
| Dec 31, 2024 | -$0.50 | -$0.27 | N/A | -85.19% | Miss | N/A | 1 | 0 up, 0 down | Feb 13, 2025 | $607494 |
| Sep 30, 2024 | -$0.70 | -$0.53 | N/A | -32.08% | Miss | N/A | N/A | 0 up, 0 down | Nov 7, 2024 | $872287 |
| Jun 30, 2024 | -$1.34 | -$0.51 | N/A | -162.75% | Miss | N/A | N/A | 0 up, 0 down | Sep 19, 2024 | $727824 |
| Mar 31, 2024 | -$14.30 | -$8.70 | -$8.70 - -$8.70 | -64.37% | Miss | N/A | 1 | 0 up, 0 down | May 8, 2024 | $823800 |
| Dec 31, 2023 | -$20.70 | -$32.40 | N/A | +36.11% | Beat | N/A | 1 | 0 up, 0 down | Feb 9, 2024 | $764063 |
| Sep 30, 2023 | -$1.04 | -$7.68 | N/A | +86.45% | Beat | N/A | N/A | 0 up, 0 down | Nov 8, 2023 | $796094 |
| Jun 30, 2023 | -$229.20 | -$178.80 | -$199.28 - -$158.46 | -28.19% | Miss | N/A | 2 | 0 up, 0 down | Aug 24, 2023 | $443135 |
| Mar 31, 2023 | -$686.40 | -$328.80 | -$328.93 - -$168.07 | -108.76% | Miss | N/A | 2 | 0 up, 0 down | May 11, 2023 | $457058 |
| Dec 31, 2022 | -$55.20 | -$264.00 | N/A | +79.09% | Beat | N/A | 1 | 0 up, 0 down | Feb 14, 2023 | $356679 |
| Sep 30, 2022 | -$0.08 | -$0.10 | N/A | +20.00% | Beat | N/A | N/A | 0 up, 0 down | Nov 9, 2022 | N/A |
| Jun 30, 2022 | -$336.00 | -$432.00 | N/A | +22.22% | Beat | N/A | N/A | N/A | Aug 31, 2022 | N/A |
| Mar 31, 2022 | -$216.00 | -$384.00 | N/A | +43.75% | Beat | N/A | N/A | N/A | May 10, 2022 | $192500 |
| Dec 31, 2021 | -$552.00 | -$384.00 | N/A | -43.75% | Miss | N/A | N/A | N/A | Feb 10, 2022 | $177791 |
| Sep 30, 2021 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 12, 2021 | N/A |
| Jun 30, 2021 | -$0.07 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 15, 2021 | $1.61M |
| Mar 31, 2021 | -$0.27 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2021 | $34290 |
| Dec 31, 2020 | -$0.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Mar 31, 2021 | $283037 |
| Sep 30, 2019 | -$0.09 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Nov 29, 2019 | N/A |
| Jun 30, 2019 | -$0.19 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jul 5, 2019 | N/A |
Annual EPS
EPS for the fiscal year ended Jun 30, 2026 was -$5.87, after -$2.08 the year before. It was -$0.19 for the year ended Jun 30, 2019, the oldest of the 7 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Jun 30, 2026 | -$5.87 | N/A |
| Jun 30, 2025 | -$2.08 | N/A |
| Jun 30, 2024 | -$37.38 | N/A |
| Jun 30, 2023 | -$970.88 | N/A |
| Jun 30, 2022 | -$1,104.27 | N/A |
| Jun 30, 2021 | -$0.66 | N/A |
| Jun 30, 2019 | -$0.19 | N/A |
Frequently Asked Questions About INBS
What EPS do analysts expect from INBS next quarter?
The consensus EPS estimate for Intelligent Bio Solutions for the quarter ending Dec 31, 2026 is -$1.36 from 1 analyst, with estimates from -$1.36 to -$1.36.
How often does INBS beat earnings estimates?
Intelligent Bio Solutions beat the EPS estimate in 1 of the 8 most recent quarters that had an estimate, with an average surprise of -185.65%.
INBS pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors